Global Patent Medicine Market Size, Status and Forecast 2024-2034
Global Patent Medicine Scope and Market Size
Patent Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Patent Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Product Patents
Process Patents
Segment by Application
Adult
Children
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer Inc.
Otsuka Pharmaceutical
Merck
Novartis
Sanofi-Aventis
Bristol-Myers Squibb Co.
GSK

Table of Content
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patent Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Product Patents
1.2.3 Process Patents
1.3 Market by Application
1.3.1 Global Patent Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adult
1.3.3 Children
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patent Medicine Market Perspective (2016-2027)
2.2 Patent Medicine Growth Trends by Regions
2.2.1 Patent Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Patent Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Patent Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Patent Medicine Industry Dynamic
2.3.1 Patent Medicine Market Trends
2.3.2 Patent Medicine Market Drivers
2.3.3 Patent Medicine Market Challenges
2.3.4 Patent Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patent Medicine Players by Revenue
3.1.1 Global Top Patent Medicine Players by Revenue (2016-2021)
3.1.2 Global Patent Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Patent Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Patent Medicine Revenue
3.4 Global Patent Medicine Market Concentration Ratio
3.4.1 Global Patent Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patent Medicine Revenue in 2020
3.5 Patent Medicine Key Players Head office and Area Served
3.6 Key Players Patent Medicine Product Solution and Service
3.7 Date of Enter into Patent Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patent Medicine Breakdown Data by Type
4.1 Global Patent Medicine Historic Market Size by Type (2016-2021)
4.2 Global Patent Medicine Forecasted Market Size by Type (2022-2027)
5 Patent Medicine Breakdown Data by Application
5.1 Global Patent Medicine Historic Market Size by Application (2016-2021)
5.2 Global Patent Medicine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Patent Medicine Market Size (2016-2027)
6.2 North America Patent Medicine Market Size by Type
6.2.1 North America Patent Medicine Market Size by Type (2016-2021)
6.2.2 North America Patent Medicine Market Size by Type (2022-2027)
6.2.3 North America Patent Medicine Market Size by Type (2016-2027)
6.3 North America Patent Medicine Market Size by Application
6.3.1 North America Patent Medicine Market Size by Application (2016-2021)
6.3.2 North America Patent Medicine Market Size by Application (2022-2027)
6.3.3 North America Patent Medicine Market Size by Application (2016-2027)
6.4 North America Patent Medicine Market Size by Country
6.4.1 North America Patent Medicine Market Size by Country (2016-2021)
6.4.2 North America Patent Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Patent Medicine Market Size (2016-2027)
7.2 Europe Patent Medicine Market Size by Type
7.2.1 Europe Patent Medicine Market Size by Type (2016-2021)
7.2.2 Europe Patent Medicine Market Size by Type (2022-2027)
7.2.3 Europe Patent Medicine Market Size by Type (2016-2027)
7.3 Europe Patent Medicine Market Size by Application
7.3.1 Europe Patent Medicine Market Size by Application (2016-2021)
7.3.2 Europe Patent Medicine Market Size by Application (2022-2027)
7.3.3 Europe Patent Medicine Market Size by Application (2016-2027)
7.4 Europe Patent Medicine Market Size by Country
7.4.1 Europe Patent Medicine Market Size by Country (2016-2021)
7.4.2 Europe Patent Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Patent Medicine Market Size (2016-2027)
8.2 Asia-Pacific Patent Medicine Market Size by Type
8.2.1 Asia-Pacific Patent Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Patent Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Patent Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Patent Medicine Market Size by Application
8.3.1 Asia-Pacific Patent Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Patent Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Patent Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Patent Medicine Market Size by Region
8.4.1 Asia-Pacific Patent Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Patent Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Patent Medicine Market Size (2016-2027)
9.2 Latin America Patent Medicine Market Size by Type
9.2.1 Latin America Patent Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Patent Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Patent Medicine Market Size by Type (2016-2027)
9.3 Latin America Patent Medicine Market Size by Application
9.3.1 Latin America Patent Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Patent Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Patent Medicine Market Size by Application (2016-2027)
9.4 Latin America Patent Medicine Market Size by Country
9.4.1 Latin America Patent Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Patent Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patent Medicine Market Size (2016-2027)
10.2 Middle East & Africa Patent Medicine Market Size by Type
10.2.1 Middle East & Africa Patent Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Patent Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Patent Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Patent Medicine Market Size by Application
10.3.1 Middle East & Africa Patent Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Patent Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Patent Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Patent Medicine Market Size by Country
10.4.1 Middle East & Africa Patent Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Patent Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer Inc.
11.1.1 Pfizer Inc. Company Details
11.1.2 Pfizer Inc. Business Overview
11.1.3 Pfizer Inc. Patent Medicine Introduction
11.1.4 Pfizer Inc. Revenue in Patent Medicine Business (2016-2021)
11.1.5 Pfizer Inc. Recent Development
11.2 Otsuka Pharmaceutical
11.2.1 Otsuka Pharmaceutical Company Details
11.2.2 Otsuka Pharmaceutical Business Overview
11.2.3 Otsuka Pharmaceutical Patent Medicine Introduction
11.2.4 Otsuka Pharmaceutical Revenue in Patent Medicine Business (2016-2021)
11.2.5 Otsuka Pharmaceutical Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Patent Medicine Introduction
11.3.4 Merck Revenue in Patent Medicine Business (2016-2021)
11.3.5 Merck Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Patent Medicine Introduction
11.4.4 Novartis Revenue in Patent Medicine Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Details
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Patent Medicine Introduction
11.5.4 Sanofi-Aventis Revenue in Patent Medicine Business (2016-2021)
11.5.5 Sanofi-Aventis Recent Development
11.6 Bristol-Myers Squibb Co.
11.6.1 Bristol-Myers Squibb Co. Company Details
11.6.2 Bristol-Myers Squibb Co. Business Overview
11.6.3 Bristol-Myers Squibb Co. Patent Medicine Introduction
11.6.4 Bristol-Myers Squibb Co. Revenue in Patent Medicine Business (2016-2021)
11.6.5 Bristol-Myers Squibb Co. Recent Development
11.7 GSK
11.7.1 GSK Company Details
11.7.2 GSK Business Overview
11.7.3 GSK Patent Medicine Introduction
11.7.4 GSK Revenue in Patent Medicine Business (2016-2021)
11.7.5 GSK Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details